Product details:
| ISBN13: | 9780443187032 |
| ISBN10: | 0443187037 |
| Binding: | Hardback |
| No. of pages: | 622 pages |
| Size: | 276x215 mm |
| Weight: | 1920 g |
| Language: | English |
| 688 |
Category:
Management, Body Systems, and Case Studies in COVID-19
Publisher: Academic Press
Date of Publication: 19 July 2024
Normal price:
Publisher's listprice:
EUR 220.00
EUR 220.00
Your price:
81 705 (77 814 HUF + 5% VAT )
discount is: 10% (approx 9 078 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
Click here to subscribe.
Availability:
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Can't you provide more accurate information?
Not in stock at Prospero.
Long description:
Management, Body Systems, and Case Studies in COVID-19 describes the assessment and treatment of patients infected with the novel coronavirus that causes the varied symptoms of COVID-19. Detailing this multisystem disease and the organs and tissues affected, this volume features chapters on several body systems. Conditions affecting the respiratory, hematological, hepatobiliary, renal, gastrointestinal, nervous, musculoskeletal, and cardiovascular systems are addressed. The fundamental role of telemedicine during the pandemic is also discussed. This volume is relevant for all clinicians and scientists working to ensure the best outcomes for patients with COVID-19.
Table of Contents:
Preface
Section A: Introductory chapters and setting the scene
1. Hand hygiene strategies
2. Approved vaccines for the COVID-19 pandemic: Linking in future perspectives
3. Molecular methods for SARS-CoV-2 variant detection
Section B: Management
4. Systematic patient assessment for acute respiratory tract ailments (SPARTA): A simple tool to improve outcomes from COVID-19
5. Point of care ultrasound for coronavirus disease 2019: The multiorgan approach to COVID-19
6. COVID-19 in patients with inflammatory bowel diseases: Features and guidelines
7. Management of COVID-19 and clinical nutrition
8. The management of head and neck cancer in COVID-19
9. The COVID-19 pandemic: Inventory management and allocation of personal protective
equipment
10. Clinical management in the COVID-19 pandemic: Rheumatic disease
11. Managing migraines during the COVID-19 pandemic: An Italian experience
12. Managing acute ischemic stroke in the SARS-CoV-2 pandemic
13. Impact of the coronavirus disease 2019 pandemic on patients with hypertension
14. Neurosurgical trauma management during COVID-19 restrictions
15. The COVID-19 pandemic and management of weight gain: Implications for obesity
16. COVID-19 and the management of heart failure using telemedicine
Section C: Guidelines for different treatment clinics
17. Guidelines for breast imaging in the COVID-19 pandemic
18. Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis, guidelines,
and reporting
19. Lung cancer in the era of COVID-19
20. Multisystem inflammatory syndrome in children/pediatric inflammatory multisystem
syndrome: Clinical guidelines
Section D: Impact on the respiratory system
21. Ground-glass nodules in the lungs of COVID-19 patients
22. Cardiothoracic imaging in patients affected by COVID-19
23. Cystic fibrosis and bronchial epithelial cells in SARS-CoV-2 infection
24. Biomechanics and mechanobiology of the lung parenchyma following SARS-CoV-2 infection
25. Long noncoding RNA profiling in respiratory specimens from COVID-19 patients
26. COVID-19 and acute pulmonary embolism
27. The usefulness of the alveolar-arteriolar gradient during the COVID-19 pandemic
Section E: Effects on cardiovascular and hematological systems
28. Cardiac manifestations of COVID-19: An overview
29. Limb ischemia and COVID-19
30. Thrombosis and coagulopathy in COVID-19: A new narrative
31. COVID-19 myocarditis: Features of echocardiography
32. COVID-19 lockdown and impact on arrhythmias
33. Cardiometabolic disease and COVID-19: A new narrative
34. Postrecovery COVID-19 and interlinking diabetes and cardiovascular events
35. COVID-19 patients and extracorporeal membrane oxygenation
36. Sars-CoV-2 infection in different hematological patients
Section F: Effects on body systems
37. Dermatological reactions associated with personal protective equipment use during
the COVID-19 pandemic
38. Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine response
39. Coinfections with COVID-19: A focus on tuberculosis (TB)
40. Patients with autoimmune liver disease and the impact of Sars-COV-2 infection
41. COVID-19 severity and nonalcoholic fatty liver disease
42. Changes in obesity and diabetes severity during the COVID-19 pandemic at Virginia
Commonwealth University health system
43. The diabetic patient and concomitant conditions rhinoorbital-cerebral mucormycosis
and COVID-19
44. Tissue location of SARS-CoV-2 RNA: A focus on bone and implications for skeletal health
45. Linking between gastrointestinal tract effects of COVID-19 and tryptophan metabolism
46. Organ damage in SARS-CoV-2 infection in children: A focus on acute kidney injury
47. Obesity, COVID-19 severity, and mortality
48. Upper and lower gastrointestinal symptoms and manifestations of COVID-19
49. The COVID-19 survivors: Impact on skeletal muscle strength
Section G: Case studies with mini review
50. A case report: COVID-19 meningoencephalitis and intracranial hemorrhage
51. Case study: Oral mucosal lesions in patients with COVID-19
52. Case study: COVID-19 pneumonia presented with cavitary lesions
53. Case study: Optic neuritis in SARS-CoV-2 infection
Section H: Resources
54. Recommended resources relevant to the body systems involvement
and management of COVID-19
Section A: Introductory chapters and setting the scene
1. Hand hygiene strategies
2. Approved vaccines for the COVID-19 pandemic: Linking in future perspectives
3. Molecular methods for SARS-CoV-2 variant detection
Section B: Management
4. Systematic patient assessment for acute respiratory tract ailments (SPARTA): A simple tool to improve outcomes from COVID-19
5. Point of care ultrasound for coronavirus disease 2019: The multiorgan approach to COVID-19
6. COVID-19 in patients with inflammatory bowel diseases: Features and guidelines
7. Management of COVID-19 and clinical nutrition
8. The management of head and neck cancer in COVID-19
9. The COVID-19 pandemic: Inventory management and allocation of personal protective
equipment
10. Clinical management in the COVID-19 pandemic: Rheumatic disease
11. Managing migraines during the COVID-19 pandemic: An Italian experience
12. Managing acute ischemic stroke in the SARS-CoV-2 pandemic
13. Impact of the coronavirus disease 2019 pandemic on patients with hypertension
14. Neurosurgical trauma management during COVID-19 restrictions
15. The COVID-19 pandemic and management of weight gain: Implications for obesity
16. COVID-19 and the management of heart failure using telemedicine
Section C: Guidelines for different treatment clinics
17. Guidelines for breast imaging in the COVID-19 pandemic
18. Vaccine-induced (immune) thrombotic thrombocytopenia (VITT): Diagnosis, guidelines,
and reporting
19. Lung cancer in the era of COVID-19
20. Multisystem inflammatory syndrome in children/pediatric inflammatory multisystem
syndrome: Clinical guidelines
Section D: Impact on the respiratory system
21. Ground-glass nodules in the lungs of COVID-19 patients
22. Cardiothoracic imaging in patients affected by COVID-19
23. Cystic fibrosis and bronchial epithelial cells in SARS-CoV-2 infection
24. Biomechanics and mechanobiology of the lung parenchyma following SARS-CoV-2 infection
25. Long noncoding RNA profiling in respiratory specimens from COVID-19 patients
26. COVID-19 and acute pulmonary embolism
27. The usefulness of the alveolar-arteriolar gradient during the COVID-19 pandemic
Section E: Effects on cardiovascular and hematological systems
28. Cardiac manifestations of COVID-19: An overview
29. Limb ischemia and COVID-19
30. Thrombosis and coagulopathy in COVID-19: A new narrative
31. COVID-19 myocarditis: Features of echocardiography
32. COVID-19 lockdown and impact on arrhythmias
33. Cardiometabolic disease and COVID-19: A new narrative
34. Postrecovery COVID-19 and interlinking diabetes and cardiovascular events
35. COVID-19 patients and extracorporeal membrane oxygenation
36. Sars-CoV-2 infection in different hematological patients
Section F: Effects on body systems
37. Dermatological reactions associated with personal protective equipment use during
the COVID-19 pandemic
38. Hemodialysis patients, effects of infections by SARS-CoV-2 and vaccine response
39. Coinfections with COVID-19: A focus on tuberculosis (TB)
40. Patients with autoimmune liver disease and the impact of Sars-COV-2 infection
41. COVID-19 severity and nonalcoholic fatty liver disease
42. Changes in obesity and diabetes severity during the COVID-19 pandemic at Virginia
Commonwealth University health system
43. The diabetic patient and concomitant conditions rhinoorbital-cerebral mucormycosis
and COVID-19
44. Tissue location of SARS-CoV-2 RNA: A focus on bone and implications for skeletal health
45. Linking between gastrointestinal tract effects of COVID-19 and tryptophan metabolism
46. Organ damage in SARS-CoV-2 infection in children: A focus on acute kidney injury
47. Obesity, COVID-19 severity, and mortality
48. Upper and lower gastrointestinal symptoms and manifestations of COVID-19
49. The COVID-19 survivors: Impact on skeletal muscle strength
Section G: Case studies with mini review
50. A case report: COVID-19 meningoencephalitis and intracranial hemorrhage
51. Case study: Oral mucosal lesions in patients with COVID-19
52. Case study: COVID-19 pneumonia presented with cavitary lesions
53. Case study: Optic neuritis in SARS-CoV-2 infection
Section H: Resources
54. Recommended resources relevant to the body systems involvement
and management of COVID-19